About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 NCCN Policy Summit
2019 MASCC/ISOO Annual Meeting
2019 ASCO Annual Meeting
ESMO World GI 2019
2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
No results found for "Jyothirmai Gubili"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
Incidence of HPV-Associated Head and Neck Cancers in the United States
Racial Reporting and Representation in Oncology Trials
Total Cumulative Chemotherapy Dose and Survival in Breast Cancer
Adavosertib Plus Gemcitabine and Radiotherapy in Locally Advanced Pancreatic Cancer
Nivolumab/Brentuximab Vedotin in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
Most Read Stories
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Single-Institution Study of Next-Generation Sequencing Outcomes in Patients With Cancer
Pooled Analysis of 4-Year Survival With Nivolumab Therapy in Patients With Previously Treated Advanced NSCLC
FDA Pipeline: Designation in CLL, New Drug Application in GIST, New Prostate Ablation System Receives 510(k) Clearance
Immune-Related Adverse Events Requiring Hospitalization in Patients Receiving Immune Checkpoint Inhibitors
© 2019 HSP News Service, L.L.C.